Liver injury due to potassium para-aminobenzoate (Potaba®) [2];Atteinte hépatique aiguë associée à la prise de para-aminobenzoate de potassium (Potaba®)

Gastroenterologie Clinique et Biologique

Volumn 28, Issue 12, 2004, Pages 1295-1296

  Mesnil, Adeline ^a   Lewden, Bénédicte ^a   Dumortier, Jérôme ^a   Cuche, Marc ^b   Euvrard, Patrice ^c   Dorez, Didier ^d   Vial, Thierry ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b Infirmerie Protestante   (France)

^c Polyclinique des Minguettes   (France)

^d CROIX ROUSSE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBENZOATE POTASSIUM; ALANINE AMINOTRANSFERASE; ALLOPURINOL; ANTIBIOTIC AGENT; ASPARTATE AMINOTRANSFERASE; ATORVASTATIN; CAPTOPRIL; GAMMA GLUTAMYLTRANSFERASE; HYDROCHLOROTHIAZIDE; ROXITHROMYCIN; SIMVASTATIN;

ADULT; ANTIBIOTIC THERAPY; CASE REPORT; CLINICAL FEATURE; DRUG EFFICACY; ECHOGRAPHY; GLUCOSURIA; HEPATOMEGALY; HUMAN; HUMAN TISSUE; HYPEREOSINOPHILIA; KIDNEY FAILURE; LETTER; LIVER TOXICITY; MALE; NEUTROPENIA; PEYRONIE DISEASE; PROTEINURIA; SCLERODERMA; SKIN BIOPSY; SYMPTOM;

EID: 11244347803     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0399-8320(04)95226-8     Document Type: Letter

References (5)

1. Hasche-Klunder R. Treatment of Peyronie's disease with para-aminobenzoacidic potassium. Urologe A 1978;17:224-7.
2. Carson CC. Potassium para-aminobenzoate for the treatment of Peyronie's disease: is it effective? Tech Urol 1997;3:135-9.
3. Ludwig G. Evaluation of conservative therapeutic approaches to Peyronie's disease (fibrotic induration of the penis). Urol Int 1991;47:236-9.
4. Kantor GR, Ratz JL. Liver toxicity from potassium para-aminobenzoate. J Am Acad Dermatol 1985;13:671-2.
5. Borum M, Nsien E, Zimmerman H. Hepatotoxicity from paraaminobenzoic acid. Dig Dis Sci 1991;36:1793.